Prophylactic scopolamine butylbromide reduced death rattle in patients in the dying phase.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35226526.
- Also identified by DOI 10.7326/J22-0005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
van Esch HJ, van Zuylen L, Geijteman ECT, et al. <b>Effect of prophylactic subcutaneous scopolamine butylbromide on death rattle in patients at the end of life: the SILENCE randomized clinical trial.</b> JAMA. 2021;326:1268-76. 34609452.
Medical subject headings
- Hydrocarbons, Brominated
- Scopolamine